Schering-Plough
SGP
#545
Rank
C$63.37 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Total debt

Total debt on the balance sheet as of December 2008 : C$11.21 Billion

According to Schering-Plough's latest financial reports the company's total debt is C$11.21 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Schering-Plough - Total debt on balance sheet (from 1996 to 2008)

Total debt by year

Year Total debt Change
2008-12-31C$9.94 B
2006-12-31C$3.09 B-27.76%
2005-12-31C$4.28 B-10.02%
2004-12-31C$4.75 B6.83%
2003-12-31C$4.45 B-34.63%
2002-12-31C$6.81 B125.05%
2001-12-31C$3.02 B-23.18%
2000-12-31C$3.94 B
1998-12-31C$3.15 B-10.06%
1997-12-31C$3.50 B130.49%
1996-12-31C$1.52 B